官方服务：
资源简介：
Hereditary cancer
应用场景：
创建时间：
2020-05-20
相关数据集
Biological and clinical features of patients from the Ma-Spore ALL 2003 trial genotyped for the BIM polymorphism.
Incidence of the BIM polymorphism is 50 out of 411 patients, or 12.2%. Abbreviations: Ma-Spore, Malaysia- Singapore; MRD, minimal residual disease; NCI, National Cancer Institute; PCR, polymerase chai
NIAID Data Ecosystem60
Identification of subtypes in HER2-positive breast cancer reveals a gene signature prognostic of outcome
Purpose HER2 gene amplification or protein overexpression (HER2+) defines a clinically challenging subgroup of breast cancer with variable prognosis and response to therapy. We aimed to investigate th
NIAID Data Ecosystem50
The effect on overall and progression-free survival of the candidate SNPs in patients with advanced ESCC under multivariate analysis.
*Adjusted for age, gender, stage, op and CCRT status. #with 2 missing values. ADD: additive; DOM: dominant; REC, recessive; MAF: minor allele frequency.
NIAID Data Ecosystem40
Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer
The goal of this study was to identify and characterize germline and somatic genetic variation in women with high grade serous ovarian cancers treated at a single cancer center and their associations
NIAID Data Ecosystem60
Gene expression data for pathological stage I-II lung adenocarcinomas. Homo sapiens
Identification of genes up-regulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. To elucidate molecular characteristics of lung adenocarcinomas (ADCs) with ALK mutations and those
NIAID Data Ecosystem50
